Signature-based approaches for informed drug repurposing: targeting CNS disorders.
Shukla R, Henkel ND, Alganem K, Hamoud AR, Reigle J, Alnafisah RS, Eby HM, Imami AS, Creeden JF, Miruzzi SA, Meller J, Mccullumsmith RE.
Shukla R, et al. Among authors: meller j.
Neuropsychopharmacology. 2021 Jan;46(1):116-130. doi: 10.1038/s41386-020-0752-6. Epub 2020 Jun 30.
Neuropsychopharmacology. 2021.
PMID: 32604402
Free PMC article.
Review.